46 related articles for article (PubMed ID: 20658957)
1. Identification of JTP-70902, a p15(INK4b)-inductive compound, as a novel MEK1/2 inhibitor.
Yamaguchi T; Yoshida T; Kurachi R; Kakegawa J; Hori Y; Nanayama T; Hayakawa K; Abe H; Takagi K; Matsuzaki Y; Koyama M; Yogosawa S; Sowa Y; Yamori T; Tajima N; Sakai T
Cancer Sci; 2007 Nov; 98(11):1809-16. PubMed ID: 17784872
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health.
Popov N; Gil J
Epigenetics; 2010; 5(8):685-90. PubMed ID: 20716961
[TBL] [Abstract][Full Text] [Related]
3. Post-GWAS functional analysis identifies CUX1 as a regulator of p16
Jiang D; Sun W; Wu T; Zou M; Vasamsetti SB; Zhang X; Zhao Y; Phillippi JA; Sawalha AH; Tavakoli S; Dutta P; Florentin J; Chan SY; Tollison TS; Di Wu ; Cui J; Huntress I; Peng X; Finkel T; Li G
Nat Aging; 2022 Feb; 2(2):140-154. PubMed ID: 37117763
[TBL] [Abstract][Full Text] [Related]
4. DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification.
Camacho CV; Todorova PK; Hardebeck MC; Tomimatsu N; Gil del Alcazar CR; Ilcheva M; Mukherjee B; McEllin B; Vemireddy V; Hatanpaa K; Story MD; Habib AA; Murty VV; Bachoo R; Burma S
Oncogene; 2015 Feb; 34(8):1064-72. PubMed ID: 24632607
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Expression of
de Souza Fernandez T; Fonseca Alvarenga T; Almeida Antônio de Kós E; Lamim Lovatel V; Tavares RC; da Costa ES; de Souza Fernandez C; Abdelhay E
Biomed Res Int; 2019; 2019():3176565. PubMed ID: 31886200
[TBL] [Abstract][Full Text] [Related]
6. Modified CDKN2B (p15) and CDKN2A (p16) DNA methylation profiles in urban pesticide applicators.
Herrera-Moreno JF; Medina-Díaz IM; Bernal-Hernández YY; Ramos KS; Alvarado-Cruz I; Quintanilla-Vega B; González-Arias CA; Barrón-Vivanco BS; Rojas-García AE
Environ Sci Pollut Res Int; 2019 May; 26(15):15124-15135. PubMed ID: 30924039
[TBL] [Abstract][Full Text] [Related]
7. CDKN2B Methylation Correlates with Survival in AML Patients.
Kamali Dolatabadi E; Ostadali Dehaghi M; Amirizadeh N; Parivar K; Mahdian R
Iran J Pharm Res; 2017; 16(4):1600-1611. PubMed ID: 29552069
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Dexheimer GM; Alves J; Reckziegel L; Lazzaretti G; Abujamra AL
Dis Markers; 2017; 2017():5472893. PubMed ID: 29038614
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.
Li MY; Xu YY; Kang HY; Wang XR; Gao L; Cen J; Wang W; Wang N; Li YH; Wang LL; Yu L
Chin Med J (Engl); 2015 Aug; 128(15):2019-25. PubMed ID: 26228212
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.
Ma D; Fang Q; Wang P; Gao R; Sun J; Li Y; Hu XY; Wang JS
Gene Ther; 2015 Apr; 22(4):287-96. PubMed ID: 25652099
[TBL] [Abstract][Full Text] [Related]
11. Potential relationship between inadequate response to DNA damage and development of myelodysplastic syndrome.
Zhou T; Chen P; Gu J; Bishop AJ; Scott LM; Hasty P; Rebel VI
Int J Mol Sci; 2015 Jan; 16(1):966-89. PubMed ID: 25569081
[TBL] [Abstract][Full Text] [Related]
12. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic as an important tool for diagnosis and prognosis for patients with hypocellular primary myelodysplastic syndrome.
de Souza DC; Fernandez Cde S; Camargo A; Apa AG; da Costa ES; Bouzas LF; Abdelhay E; Fernandez Tde S
Biomed Res Int; 2014; 2014():542395. PubMed ID: 25180186
[TBL] [Abstract][Full Text] [Related]
14. Human induced pluripotent stem cells from basic research to potential clinical applications in cancer.
Fernandez Tde S; de Souza Fernandez C; Mencalha AL
Biomed Res Int; 2013; 2013():430290. PubMed ID: 24288679
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Status and Methylation Pattern in Promoter of P15INK4b and P16INK4a in Cord Blood CD34 (+) Stem Cells.
Azad M; Kaviani S; Noruzinia M; Mortazavi Y; Mobarra N; Alizadeh S; Shahjahani M; Skandari F; Ahmadi MH; Atashi A; Abroun S; Zonoubi Z
Iran J Basic Med Sci; 2013 Jul; 16(7):822-8. PubMed ID: 23997911
[TBL] [Abstract][Full Text] [Related]
16. Histone methylation in myelodysplastic syndromes.
Wei Y; Gañán-Gómez I; Salazar-Dimicoli S; McCay SL; Garcia-Manero G
Epigenomics; 2011 Apr; 3(2):193-205. PubMed ID: 22122281
[TBL] [Abstract][Full Text] [Related]
17. The Promise and the Problems of Epigenetics Biomarkers in Cancer.
Lorincz AT
Expert Opin Med Diagn; 2011 Sep; 5(5):375-379. PubMed ID: 22003365
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic alterations of p15(INK4B) and p16(INK4A) genes in pediatric primary myelodysplastic syndrome.
Rodrigues EF; Santos-Rebouças CB; Gonçalves Pimentel MM; Mencalha AL; Dobbin J; Da Costa ES; Fernandez Cde S; Bouzas LF; Abdelhay E; De Souza Fernandez T
Leuk Lymphoma; 2010 Oct; 51(10):1887-94. PubMed ID: 20658957
[TBL] [Abstract][Full Text] [Related]
19. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
